epigallocatechin gallate has been researched along with Uveal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CW; Chen, Y; Hsieh, YH; Hu, DN; Yang, SF; Yang, WE | 1 |
1 other study(ies) available for epigallocatechin gallate and Uveal Neoplasms
| Article | Year |
|---|---|
Epigallocatechingallate inhibits migration of human uveal melanoma cells via downregulation of matrix metalloproteinase-2 activity and ERK1/2 pathway.
Topics: Catechin; Cell Line, Tumor; Cell Movement; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Melanoma; Phosphorylation; Uveal Neoplasms | 2014 |